FHIR © HL7.org  |  Server Home  |  XIG Home  |  XIG Stats  |  Server Source  |  FHIR  

FHIR IG Statistics: ValueSet/2.16.840.1.113762.1.4.1206.56

Packageus.nlm.vsac
Resource TypeValueSet
Id2.16.840.1.113762.1.4.1206.56
FHIR VersionR4
Sourcehttp://fhir.org/packages/us.nlm.vsac/https://vsac.nlm.nih.gov/valueset/2.16.840.1.113762.1.4.1206.56/expansion
URLhttp://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1206.56
Version20240719
Statusactive
Date2024-07-19T01:06:46-04:00
NameFOBT_Lab
TitleFOBT_Lab
Realmus
Authorityhl7
Purpose(Clinical Focus: The intent of this value set is for the purpose of defining the clinical codes that constitute FOBT Lab.),(Data Element Scope: FOBT Lab),(Inclusion Criteria: The intent of this value set is for the purpose of defining the clinical codes that constitute FOBT Lab.),(Exclusion Criteria: N/A)

Resources that use this resource

ValueSet
2.16.840.1.113762.1.4.1206.57Colorectal Screening

Resources that this resource uses

CodeSystem
cptCurrent Procedural Terminology (CPT®)

Narrative

No narrative content found in resource


Source

{
  "resourceType": "ValueSet",
  "id": "2.16.840.1.113762.1.4.1206.56",
  "meta": {
    "versionId": "8",
    "lastUpdated": "2024-07-19T01:06:46.000-04:00",
    "profile": [
      "http://hl7.org/fhir/StructureDefinition/shareablevalueset",
      "http://hl7.org/fhir/us/cqfmeasures/StructureDefinition/computable-valueset-cqfm",
      "http://hl7.org/fhir/us/cqfmeasures/StructureDefinition/publishable-valueset-cqfm"
    ]
  },
  "extension": [
    {
      "url": "http://hl7.org/fhir/StructureDefinition/valueset-author",
      "valueContactDetail": {
        "name": "Brigham and Women’s Hospital Author"
      }
    },
    {
      "url": "http://hl7.org/fhir/StructureDefinition/resource-lastReviewDate",
      "valueDate": "2024-07-19"
    },
    {
      "url": "http://hl7.org/fhir/StructureDefinition/valueset-effectiveDate",
      "valueDate": "2024-07-19"
    }
  ],
  "url": "http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1206.56",
  "identifier": [
    {
      "system": "urn:ietf:rfc:3986",
      "value": "urn:oid:2.16.840.1.113762.1.4.1206.56"
    }
  ],
  "version": "20240719",
  "name": "FOBT_Lab",
  "title": "FOBT_Lab",
  "status": "active",
  "date": "2024-07-19T01:06:46-04:00",
  "publisher": "Brigham and Women’s Hospital Steward",
  "jurisdiction": [
    {
      "coding": [
        {
          "system": "urn:iso:std:iso:3166",
          "code": "US"
        }
      ]
    }
  ],
  "purpose": "(Clinical Focus: The intent of this value set is for the purpose of defining the clinical codes that constitute FOBT Lab.),(Data Element Scope: FOBT Lab),(Inclusion Criteria: The intent of this value set is for the purpose of defining the clinical codes that constitute FOBT Lab.),(Exclusion Criteria: N/A)",
  "compose": {
    "include": [
      {
        "system": "http://www.ama-assn.org/go/cpt",
        "concept": [
          {
            "code": "81528",
            "display": "Oncology (colorectal) screening, quantitative real-time target and signal amplification of 10 DNA markers (KRAS mutations, promoter methylation of NDRG4 and BMP3) and fecal hemoglobin, utilizing stool, algorithm reported as a positive or negative result"
          },
          {
            "code": "82270",
            "display": "Blood, occult, by peroxidase activity (eg, guaiac), qualitative; feces, consecutive collected specimens with single determination, for colorectal neoplasm screening (ie, patient was provided 3 cards or single triple card for consecutive collection)"
          },
          {
            "code": "82274",
            "display": "Blood, occult, by fecal hemoglobin determination by immunoassay, qualitative, feces, 1-3 simultaneous determinations"
          }
        ]
      }
    ]
  },
  "expansion": {
    "identifier": "urn:uuid:6c9b0418-7fd8-4fac-9531-96b616bb7e8d",
    "timestamp": "2025-05-23T19:19:18-04:00",
    "total": 3,
    "contains": [
      {
        "system": "http://www.ama-assn.org/go/cpt",
        "version": "2025",
        "code": "81528",
        "display": "Oncology (colorectal) screening, quantitative real-time target and signal amplification of 10 DNA markers (KRAS mutations, promoter methylation of NDRG4 and BMP3) and fecal hemoglobin, utilizing stool, algorithm reported as a positive or negative result"
      },
      {
        "system": "http://www.ama-assn.org/go/cpt",
        "version": "2025",
        "code": "82270",
        "display": "Blood, occult, by peroxidase activity (eg, guaiac), qualitative; feces, consecutive collected specimens with single determination, for colorectal neoplasm screening (ie, patient was provided 3 cards or single triple card for consecutive collection)"
      },
      {
        "system": "http://www.ama-assn.org/go/cpt",
        "version": "2025",
        "code": "82274",
        "display": "Blood, occult, by fecal hemoglobin determination by immunoassay, qualitative, feces, 1-3 simultaneous determinations"
      }
    ]
  }
}